Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
or

Discovery Labs Inc (DSCO)

Discovery Labs Inc (DSCO)
3.50 -0.36 (-9.33%) 04/18/16 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
Quote Overview for Mon, Apr 18th, 2016
Day Low
3.50
Day High
3.86
Open 3.86
Previous Close 3.86 3.86
Volume 291,800 291,800
Avg Vol 180,740 180,740
Stochastic %K 91.40% 91.40%
Weighted Alpha -82.30 -82.30
5-Day Change +0.47 (+15.51%) +0.47 (+15.51%)
52-Week Range 1.42 - 18.34 1.42 - 18.34
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 31,620
  • Shares Outstanding, K 8,150
  • Annual Sales, $ 990 K
  • Annual Income, $ -55,170 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 1.65
  • Price/Sales 17.70
  • Price/Cash Flow N/A
  • Price/Book 3.45
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -6.30
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 05/05/16
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/16
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -1.96
  • Growth Rate Est. (year over year) +51,069.39%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.43 +144.76%
on 03/29/16
Period Open: 1.65
3.93 -10.94%
on 04/15/16
+1.85 (+112.12%)
since 03/18/16
3-Month
1.42 +146.48%
on 01/26/16
Period Open: 2.66
3.93 -10.94%
on 04/15/16
+0.84 (+31.58%)
since 01/15/16
52-Week
1.42 +146.48%
on 01/26/16
Period Open: 15.68
18.34 -80.92%
on 04/22/15
-12.18 (-77.68%)
since 04/17/15

Business Summary

Discovery Laboratories, Inc., formerly known as Ansan Pharmaceuticals, Inc., is a development-stage pharmaceutical company that focuses on developing compounds to treat respiratory diseases that affect the ability of the lungs to absorb oxygen. It is initially developing its lead product candidate, Surfaxin,...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 3.98
1st Resistance Point 3.74
Last Price 3.50
1st Support Level 3.38
2nd Support Level 3.26
3rd Support Level N/A

See More

52-Week High 18.34
Fibonacci 61.8% 11.88
Fibonacci 50% 9.88
Fibonacci 38.2% 7.88
Last Price 3.50
52-Week Low 1.42

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective